Boston Scientific has agreed to acquire a 15 percent equity stake in Neovasc, as well as the company’s advanced biological tissue business for $75 million in cash.

During the past few years, payers have shifted away from fee-for-service payment models and started holding clinicians more responsible for collaborating, keeping costs down and improving the quality of care. A recent review suggests that early adopters of the alternative payment models could benefit in the future when the models become more popular and penalties increase.

Edwards Lifesciences has agreed to acquire Valtech Cardio in a cash and stock deal valued at $340 million at closing, which is expected early next year.

For fiscal year (FY) 2016, Medtronic generated $28.8 billion in revenue and $3.5 billion in net earnings and achieved several milestones pertaining to research and philanthropy.

Shockwave Medical has received $45 million in Series C financing, which the company plans to use to develop the its lithoplasty balloon catheter platform.

Physicians suffer more burnout at rates much higher than the typical American worker—and their exhaustion is causing medical errors and costing hospitals money. 

MedNet, a remote cardiac monitoring company, agreed to pay more than $1.35 million to resolve kickback and false Medicare claims allegations. The U.S. Attorney’s office in New Jersey announced the settlement Nov. 15 and said there had been no determination of liability.

The market for interventional cardiology and peripheral vascular devices is expected to grow at a compound annual growth rate of 9.7 percent from 2016 to 2022, reaching $25 billion by 2022.